OncoTree: A Cancer Classification System for Precision Oncology.


Journal

JCO clinical cancer informatics
ISSN: 2473-4276
Titre abrégé: JCO Clin Cancer Inform
Pays: United States
ID NLM: 101708809

Informations de publication

Date de publication:
02 2021
Historique:
entrez: 24 2 2021
pubmed: 25 2 2021
medline: 1 9 2021
Statut: ppublish

Résumé

Cancer classification is foundational for patient care and oncology research. Systems such as International Classification of Diseases for Oncology (ICD-O), Systematized Nomenclature of Medicine Clinical Terms (SNOMED-CT), and National Cancer Institute Thesaurus (NCIt) provide large sets of cancer classification terminologies but they lack a dynamic modernized cancer classification platform that addresses the fast-evolving needs in clinical reporting of genomic sequencing results and associated oncology research. To meet these needs, we have developed OncoTree, an open-source cancer classification system. It is maintained by a cross-institutional committee of oncologists, pathologists, scientists, and engineers, accessible via an open-source Web user interface and an application programming interface. OncoTree currently includes 868 tumor types across 32 organ sites. OncoTree has been adopted as the tumor classification system for American Association for Cancer Research (AACR) Project Genomics Evidence Neoplasia Information Exchange (GENIE), a large genomic and clinical data-sharing consortium, and for clinical molecular testing efforts at Memorial Sloan Kettering Cancer Center and Dana-Farber Cancer Institute. It is also used by precision oncology tools such as OncoKB and cBioPortal for Cancer Genomics. OncoTree is a dynamic and flexible community-driven cancer classification platform encompassing rare and common cancers that provides clinically relevant and appropriately granular cancer classification for clinical decision support systems and oncology research.

Identifiants

pubmed: 33625877
doi: 10.1200/CCI.20.00108
pmc: PMC8240791
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

221-230

Subventions

Organisme : NCI NIH HHS
ID : K12 CA184746
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA008748
Pays : United States
Organisme : NINDS NIH HHS
ID : R35 NS105109
Pays : United States

Références

JCO Clin Cancer Inform. 2020 Aug;4:691-699
pubmed: 32755461
N Engl J Med. 2014 Dec 4;371(23):2189-2199
pubmed: 25409260
Eur J Cancer. 2019 Jul;115:57-60
pubmed: 31108243
Cancer Discov. 2017 Aug;7(8):818-831
pubmed: 28572459
Nature. 2018 Feb 8;554(7691):189-194
pubmed: 29420467
Sci Signal. 2013 Apr 02;6(269):pl1
pubmed: 23550210
N Engl J Med. 2015 Jun 25;372(26):2509-20
pubmed: 26028255
JCO Precis Oncol. 2017 Jul;2017:
pubmed: 28890946
Nucleic Acids Res. 2004 Jan 1;32(Database issue):D267-70
pubmed: 14681409
Nat Med. 2017 Jun;23(6):703-713
pubmed: 28481359
Blood. 2016 May 19;127(20):2391-405
pubmed: 27069254
Blood. 2016 May 19;127(20):2375-90
pubmed: 26980727
Tumour Biol. 2020 Feb;42(2):1010428320907544
pubmed: 32098581

Auteurs

Ritika Kundra (R)

Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY.

Hongxin Zhang (H)

Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY.

Robert Sheridan (R)

Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY.

Sahussapont Joseph Sirintrapun (SJ)

Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY.

Avery Wang (A)

Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY.

Angelica Ochoa (A)

Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY.

Manda Wilson (M)

Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY.

Benjamin Gross (B)

Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY.

Yichao Sun (Y)

Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY.

Ramyasree Madupuri (R)

Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY.

Baby A Satravada (BA)

Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY.

Dalicia Reales (D)

Clinical Research Administration, Memorial Sloan Kettering Cancer Center, New York, NY.

Efsevia Vakiani (E)

Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY.

Hikmat A Al-Ahmadie (HA)

Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY.

Ahmet Dogan (A)

Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY.

Maria Arcila (M)

Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.

Ahmet Zehir (A)

Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY.

Steven Maron (S)

Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.

Michael F Berger (MF)

Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY.
Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY.
Human Oncology and Pathogenesis Program, Memorial Sloan Kettering, New York, NY.

Cristina Viaplana (C)

Oncology Data Science (ODysSey Group), Vall d'Hebron Institute of Oncology, Barcelona, Spain.

Katherine Janeway (K)

Pediatrics, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA.

Matthew Ducar (M)

Foundation Medicine, Boston, MA.

Lynette Sholl (L)

Department of Pathology, Brigham and Women's Hospital, Boston, MA.
Department of Pathology, Harvard Medical School, Boston, MA.

Snjezana Dogan (S)

Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY.

Philippe Bedard (P)

Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY.
Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada.

Lea F Surrey (LF)

Cancer Genomics Program, Princess Margaret Cancer Centre, Toronto, ON, Canada.
Department of Genomic Diagnostics, Children's Hospital of Philadelphia, Philadelphia, PA.

Iker Huerga Sanchez (IH)

Tempus Labs Inc, New York, NY.

Aijaz Syed (A)

Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY.

Anoop Balakrishnan Rema (AB)

Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY.

Debyani Chakravarty (D)

Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY.

Sarah Suehnholz (S)

Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY.

Moriah Nissan (M)

Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY.

Gopakumar V Iyer (GV)

Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.

Rajmohan Murali (R)

Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY.

Nancy Bouvier (N)

Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY.

Robert A Soslow (RA)

Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY.

David Hyman (D)

Loxo Oncology Inc, Stamford, CT.

Anas Younes (A)

AstraZeneca, US, Wilmington, DE.

Andrew Intlekofer (A)

Human Oncology and Pathogenesis Program, Memorial Sloan Kettering, New York, NY.

James J Harding (JJ)

Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.
Department of Medicine, Weill Cornell Medical College, New York, NY.

Richard D Carvajal (RD)

Department of Medicine, Columbia University Medical Center, New York, NY.

Paul J Sabbatini (PJ)

Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.
Department of Medicine, Weill Cornell Medical College, New York, NY.

Ghassan K Abou-Alfa (GK)

Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.

Luc Morris (L)

Human Oncology and Pathogenesis Program, Memorial Sloan Kettering, New York, NY.
Immunogenomics and Precision Oncology Platform, Memorial Sloan Kettering, New York, NY.
Department of Surgery, Memorial Sloan Kettering, New York, NY.

Yelena Y Janjigian (YY)

Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.

Meighan M Gallagher (MM)

ExecuPharm, King of Prussia, PA.

Tara A Soumerai (TA)

Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA.

Ingo K Mellinghoff (IK)

Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.
Human Oncology and Pathogenesis Program, Memorial Sloan Kettering, New York, NY.

Abraham A Hakimi (AA)

Department of Urology, Memorial Sloan Kettering Cancer Center, New York, NY.

Matthew Fury (M)

Regeneron Pharmaceuticals, Tarrytown, NY.

Jason T Huse (JT)

Departments of Pathology and Translational Molecular Pathology, University of Texas, MD Anderson Cancer Center, Houston, TX.

Aditya Bagrodia (A)

Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX.

Meera Hameed (M)

Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY.

Stacy Thomas (S)

Information Systems, Memorial Sloan Kettering Cancer Center, New York, NY.

Stuart Gardos (S)

Information Systems, Memorial Sloan Kettering Cancer Center, New York, NY.

Ethan Cerami (E)

Department of Data Sciences, Dana-Farber Cancer Institute, Boston, MA.

Tali Mazor (T)

Knowledge Systems Group, Dana-Farber Cancer Institute, Boston, MA.

Priti Kumari (P)

Knowledge Systems Group, Dana-Farber Cancer Institute, Boston, MA.

Pichai Raman (P)

GlaxoSmithKline.

Priyanka Shivdasani (P)

Department of Pathology, Brigham and Women's Hospital, Boston, MA.

Suzanne MacFarland (S)

Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, PA.
University of Pennsylvania School of Medicine, Philadelphia, PA.

Scott Newman (S)

Department of Computational Biology, St Jude Children's Research Hospital, Memphis, TN.

Angela Waanders (A)

Children's Hospital of Chicago, Chicago, IL.

Jianjiong Gao (J)

Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY.

David Solit (D)

Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY.
Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.
Human Oncology and Pathogenesis Program, Memorial Sloan Kettering, New York, NY.
Department of Medicine, Columbia University Medical Center, New York, NY.

Nikolaus Schultz (N)

Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY.
Human Oncology and Pathogenesis Program, Memorial Sloan Kettering, New York, NY.
Department of Epidemiology and Biostatistics, Memorial Sloan Kettering, New York, NY.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH